This association highlights a potential mechanistic link between BTBD19 and tumor immune evasion: upregulated PD-L1/PD-1 signaling within the TME dampens cytotoxic T-cell activity, thereby enabling tumors to circumvent immune surveillance. This evidence concerns the gene CD274 and neoplasm.